KFSHRC Showcases Healthcare Innovations at 2024 NYC C3 Summit

KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare

RIYADH, Saudi Arabia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully concluded its participation at the 2024 NYC C3 Summit Davos of Healthcare, solidifying its leadership in healthcare innovation and transformation. As a C3 Strategic Partner and Scientific Committee Chair, KFSHRC was instrumental in shaping discussions on the future of healthcare and addressing some of the most pressing global healthcare challenges. Key presentations focused on biotechnology, artificial intelligence (AI), robotics, and precision medicine. A major highlight of the event was the recognition of KFSHRC's Deputy Chief Executive Officer (DCEO), Dr. Björn Zoéga, who was awarded the 2024 C3 Global Innovative Healthcare & Impact Transformation Award. This prestigious award celebrates Dr. Zoéga's and KFSHRC's commitment to enhancing patient care through novel solutions, improving accessibility, and reducing healthcare costs, all while promoting sustainability and social responsibility. Throughout the summit, KFSHRC leaders, including Dr. Zoéga, Dr. Edward Cupler, Executive Director of Research and Innovation, Dr. Feras Khaliel, Head of Cardiac Surgery and Director of the Robotics and Minimally Invasive Surgery Program, and Dr. Salah Baz, Head of Genomic Medicine, led several sessions covering insightful discussions around advanced medical technologies. Dr. Cupler shared insights into KFSHRC's progress in introducing Saudi Arabia as a global Biotech powerhouse, while Dr. Khaliel explored the use of robotics in surgery. Dr. Baz's session on whole genome sequencing (WGS) highlighted the technology's potential in diagnosing rare diseases and advancing personalized care. Looking ahead, KFSHRC is committed to expanding its global partnerships and continuing its mission to deliver accessible, patient-centered, and technology-driven healthcare solutions that have a lasting impact on patients worldwide. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals. Media Contact: Essam AlZahrani +966 55 525 4429 [email protected] A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/7a791969-8a59-4508-9e5f-02ea2a0d0853 Market News and Data brought to you by Benzinga APIs

KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations

RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) leads healthcare innovation, leveraging AI-driven patient management, remote diagnostics, and robotic surgeries. It contributes to Saudi Vision 2030 and is projected to add up to $27 billion to the Kingdom's medical sector by 2030. KFSHRC's robotic surgery program has set new precision and patient care benchmarks. In 2023, 1,195 robotic-assisted surgeries were performed, including the world's first fully robotic liver transplant. The program significantly enhanced surgical accuracy and reduced recovery times. KFSHRC's Robotic Cardiac Surgery Program boasts the highest volume of robotic cardiac surgeries outside the USA and ranks in the top five worldwide, with a 98% survival rate in over 400 surgeries. The program excels in complex procedures like multi-valve operations and aortic valve replacements. Using advanced robotic systems and minimally invasive surgeries in these operations has proven to reduce pain, shorten hospital stays by over 50%, and reduce costs by 40% compared to conventional methods. Meanwhile, KFSHRC's AI-powered Capacity Command Centre has conducted over 170,000 interventions since 2021, reducing bed waiting times from 81% and emergency department wait times by 14%. In radiology, AI tools boosted diagnostic accuracy by 25% and decreased misdiagnosis rates by 18%, ensuring timely, accurate care. Remote diagnostics have expanded healthcare access in underserved regions. KFSHRC utilizes advanced telemedicine platforms to provide timely consultations and specialized diagnoses. At the C3 Summit, the Davos of Healthcare in New York, Dr. Feras Khaliel, Head of Cardiac Surgery and Director of the Robotics and Minimally Invasive Surgery Program at KFSHRC, stated, "KFSHRC's integration of AI and robotics is setting new standards in precision surgery by enhancing patient safety and making previously high-risk surgeries possible with minimal invasiveness''. It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals. Media Contact: Essam AlZahrani +966 55 525 4429 [email protected] A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5ec19b4b-c169-437c-8f98-eb1f5a7dc229 Market News and Data brought to you by Benzinga APIs

KFSHRC celebrates landmark contributions at 2024 NYC C3 Summit Davos of Healthcare

As a C3 Strategic Partner and Scientific Committee Chair, KFSHRC was instrumental in shaping discussions on the future of healthcare King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully concluded its participation at the 2024 NYC C3 Summit Davos of Healthcare, solidifying its leadership in healthcare innovation and transformation. As a C3 Strategic Partner and Scientific Committee Chair, KFSHRC was instrumental in shaping discussions on the future of healthcare and addressing some of the most pressing global healthcare challenges. Key presentations focused on biotechnology, artificial intelligence (AI), robotics, and precision medicine. A major highlight of the event was the recognition of KFSHRC's Deputy Chief Executive Officer (DCEO), Dr. Björn Zoéga, who was awarded the 2024 C3 Global Innovative Healthcare & Impact Transformation Award. This prestigious award celebrates Dr. Zoéga's and KFSHRC's commitment to enhancing patient care through novel solutions, improving accessibility, and reducing healthcare costs, all while promoting sustainability and social responsibility. Throughout the summit, KFSHRC leaders, including Dr. Zoéga, Dr. Edward Cupler, Executive Director of Research and Innovation, Dr. Feras khaliel, Head of Cardiac Surgery and Director of the Robotics and Minimally Invasive Surgery Program, and Dr. Salah Baz, Head of Genomic Medicine, led several sessions covering insightful discussions around advanced medical technologies. Dr. Cupler shared insights into KFSHRC's progress in introducing Saudi Arabia as a global Biotech powerhouse, while Dr. khaliel explored the use of robotics in surgery. Dr. Baz's session on whole genome sequencing (WGS) highlighted the technology's potential in diagnosing rare diseases and advancing personalized care. Looking ahead, KFSHRC is committed to expanding its global partnerships and continuing its mission to deliver accessible, patient-centered, and technology-driven healthcare solutions that have a lasting impact on patients worldwide. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals.

KFSHRC Drives Saudi Arabia's Rise as Global Biotech Powerhouse

RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leading Saudi Arabia's efforts to become a global biotechnology powerhouse by pioneering advancements in genomics, biomanufacturing, and sustainable healthcare practices. A key achievement for KFSHRC is the localization of CAR T-cell production, making it the first in Saudi Arabia to produce these therapeutic cells internally, reducing treatment costs by 80% and accelerating access to life-saving therapies. The hospital's Genomics Centre leads in precision medicine, utilizing advanced genetic analysis to develop personalized treatments, while the Oncology Centre leverages these genomic insights to set standards in cancer care. KFSHRC researchers developed the first genetically engineered mice in the Kingdom using CRISPR-Cas9 gene-editing technology, marking another significant breakthrough in biomedical research. KFSHRC is central to Saudi Arabia's biotechnology ecosystem, leveraging the Kingdom's strategic geographic location between Europe, Asia, and Africa. In collaboration with the King Abdulaziz City for Science and Technology (KACST), KFSHRC helped establish the National Biotechnology Centre to translate scientific discoveries into viable industries. Dr. Edward Cupler, Executive Director of the Research and Innovation at KFSHRC, stated in his remarks at the C3 Summit, the Davos of Healthcare, in New York, "Saudi Arabia's vision to become a biotechnology powerhouse is within reach, driven by KFSHRC's pioneering innovations in CAR T-cell therapy, genomics, and AI." To sustain this growth, KFSHRC has developed comprehensive education and training programs in genomics, regenerative medicine, and bioinformatics to build local expertise, reduce reliance on imports, and foster biotech self-sufficiency. These efforts also include ensuring a skilled workforce that attracts global talent, reinforcing Saudi Arabia's position as a rising biotechnology leader. Leveraging these favorable conditions, KFSHRC is at the forefront of translating the National Biotechnology Strategy into reality. It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals. Media Contact: Essam AlZahrani +966 55 525 4429 [email protected] A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3170f2a8-312a-4ccd-bdec-32041da004e4 Market News and Data brought to you by Benzinga APIs